Sopheon PLC
17 August 2007
17 August 2007
SOPHEON PLC
Sopheon plc (AIM: SPE) is pleased to announce that the information required by
the new AIM Rule 26 is available on the investors page at http://www.sopheon.com
For further information contact:
Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735
Arif Karimjee, CFO
David Newton, Nominated Seymour Pierce Tel: +44 (0) 207 107 8000
Adviser Limited
Adam Reynolds Hansard Tel : + 44 (0) 207 245 1100
Communications
Andrew Tan Tel : + 44 (0) 7957 203 685
About Sopheon
Sopheon is an international provider of software and services that help
organizations improve the business impact of product innovation. The Sopheon
Accolade(R) product innovation process and portfolio management system automates
gate- or phase-based product development processes and provides strategic
decision support that allows companies to increase revenue and profits from new
products. Sopheon is listed on the AIM Market of the London Stock Exchange and
on the Euronext in the Netherlands. For more information, please visit
www.sopheon.com.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.